Praxis Precision Medicines Statistics
Share Statistics
Praxis Precision Medicines has 18.64M shares outstanding. The number of shares has increased by 40.79% in one year.
| Shares Outstanding | 18.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 4.96% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 17.30M |
| Failed to Deliver (FTD) Shares | 238.95K |
| FTD / Avg. Volume | 72.71% |
Short Selling Information
The latest short interest is 1.53M, so 8.23% of the outstanding shares have been sold short.
| Short Interest | 1.53M |
| Short % of Shares Out | 8.23% |
| Short % of Float | 8.87% |
| Short Ratio (days to cover) | 5.12 |
Valuation Ratios
The PE ratio is -1.19 and the forward PE ratio is -7.6.
| PE Ratio | -1.19 |
| Forward PE | -7.6 |
| PS Ratio | 60.04 |
| Forward PS | 33.4 |
| PB Ratio | 2.11 |
| P/FCF Ratio | -1.32 |
| PEG Ratio | n/a |
Enterprise Valuation
Praxis Precision Medicines Inc. has an Enterprise Value (EV) of 68.12M.
| EV / Earnings | -0.55 |
| EV / Sales | 27.84 |
| EV / EBITDA | -0.54 |
| EV / EBIT | -0.54 |
| EV / FCF | -0.61 |
Financial Position
The company has a current ratio of 5.39, with a Debt / Equity ratio of 0.
| Current Ratio | 5.39 |
| Quick Ratio | 5.39 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.77% and return on capital (ROIC) is -175.12%.
| Return on Equity (ROE) | -1.77% |
| Return on Assets (ROA) | -1.4% |
| Return on Capital (ROIC) | -175.12% |
| Revenue Per Employee | 29.84K |
| Profits Per Employee | -1.50M |
| Employee Count | 82 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 220.8% in the last 52 weeks. The beta is 2.69, so Praxis Precision Medicines 's price volatility has been higher than the market average.
| Beta | 2.69 |
| 52-Week Price Change | 220.8% |
| 50-Day Moving Average | 74.29 |
| 200-Day Moving Average | 58.1 |
| Relative Strength Index (RSI) | 61.23 |
| Average Volume (20 Days) | 328.62K |
Income Statement
In the last 12 months, Praxis Precision Medicines had revenue of 2.45M and earned -123.28M in profits. Earnings per share was -18.69.
| Revenue | 2.45M |
| Gross Profit | 2.45M |
| Operating Income | -126.37M |
| Net Income | -123.28M |
| EBITDA | -125.94M |
| EBIT | -126.37M |
| Earnings Per Share (EPS) | -18.69 |
Balance Sheet
The company has 81.30M in cash and 2.50M in debt, giving a net cash position of 78.81M.
| Cash & Cash Equivalents | 81.30M |
| Total Debt | 2.50M |
| Net Cash | 78.81M |
| Retained Earnings | -653.92M |
| Total Assets | 416.26M |
| Working Capital | 327.19M |
Cash Flow
In the last 12 months, operating cash flow was -111.14M and capital expenditures -50.00K, giving a free cash flow of -111.19M.
| Operating Cash Flow | -111.14M |
| Capital Expenditures | -50.00K |
| Free Cash Flow | -111.19M |
| FCF Per Share | -16.86 |
Margins
Gross margin is 10.00K%, with operating and profit margins of -516.44K% and -503.79K%.
| Gross Margin | 10.00K% |
| Operating Margin | -516.44K% |
| Pretax Margin | -503.79K% |
| Profit Margin | -503.79K% |
| EBITDA Margin | -5.15K% |
| EBIT Margin | -5.16K% |
| FCF Margin | -4.54K% |
Dividends & Yields
PRAX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -23.13% |
| FCF Yield | -7.38% |
Analyst Forecast
The average price target for PRAX is $150, which is 85.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $150 |
| Price Target Difference | 85.6% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
Stock Splits
The last stock split was on Nov 29, 2023. It was a backward split with a ratio of 1:15.
| Last Split Date | Nov 29, 2023 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | 22.75 |
| Piotroski F-Score | 4 |